Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The database provides information to clinicians, researchers, data scientists, patients and patient advocates around the world.
People who received preoperative gemcitabine and Teysuno lived 10 months longer.
A third of patients taking neoadjuvant Opdivo had complete responses in an early analysis.
Senator Dan Seum said using the drug made a major difference during his recent treatment.
Keytruda improved survival in people with favorable tumor biomarkers.
But new vaccines hold promise for prevention.
Women who chose to participate in an organized breast cancer screening program had significantly lower mortality risk than women who didn’t.
Brain cancer patient begins treatment with experimental vaccine.
Researchers say the biomarker could help noninvasively diagnose precancerous lung growths and distinguish them from benign nodules.
Guidelines are continuing to evolve to meet the changing landscape of cancer and the new technologies to find and treat it.
New tech is giving scientists unprecedented insights into single cells’ inner workings.
Cabometyx is the third liver cancer drug approved in the past six months.
Those who exercise build up less liver fat, which is tied to inflammation that may give rise to cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.